Amberlyst IR-15 (sulfonated polystyrene macroreticular resin, 20% divinylbenzene, 4.7 mmol S/g) was purchased from Alfa Aesar. Deloxan ASP I/9 (polysiloxane supported alkyl sulfonic acid 0.1-0.4 mm particle size, 0.80 mmol S/g) was a gift from Degussa (currently not commercially available). SAC-13 (nafion-silica composite, 13% wt nafion content, 0.17 mmol S/g) was a gift from Dupont (currently not commercially available).
Materials and Methods
Amberlyst IR-15 (sulfonated polystyrene macroreticular resin, 20% divinylbenzene, 4.7 mmol S/g) was purchased from Alfa Aesar. Deloxan ASP I/9 (polysiloxane supported alkyl sulfonic acid 0.1-0.4 mm particle size, 0.80 mmol S/g) was a gift from Degussa (currently not commercially available). SAC-13 (nafion-silica composite, 13% wt nafion content, 0.17 mmol S/g) was a gift from Dupont (currently not commercially available).
Sulfonated hydrothermal carbon (SHTC, 0.80 mmol S/g) was prepared in two steps from Dglucose, first a hydrothermal synthesis at 195°C and then sulfonation with concentrated sulfuric acid at 150°C, as previously described [1] . Amberlite IRA-400 (trimethylbenzylammonium substituted gel type polystyrene resin, 8% divinylbenzene, basic form, 3.8 mmol/g) was purchased from Carlo Erba. TBD-PS (1,5,7-triazabicyclo [4.4 .0]dec-5-ene supported on gel type polystyrene, 1% divinylbenzene, 3.0 mmol/g) and TBD-SiO2 (1,5,7-triazabicyclo [4.4 .0]dec-5-ene supported on silica gel, 0.7 mmol/g) were purchased from Aldrich. All the catalysts were dried at 100ºC under vacuum overnight prior to use.
Solvents were dried following standard procedures and all the reactions were carried out under argon atmosphere. OH Methyl quinate (4a) [5] [6] [7] . To a solution of quinic acid (192 mg, 1 mmol) in methanol (4 mL) was added deloxan (13 mg, 0.01 mmol). The mixture was stirred at 65 ºC for 48 h, then the acid catalyst was removed by filtration and the filtrate was concentrated under vaccum. The product was crystallized from dichloromethane/methanol affording the compound 4a (165 mg, 80 % 
Ethyl quinate (4b).
To a solution of quinic acid (192 mg, 1 mmol) in ethanol (4 mL) was added SHTC (13 mg, 0.01 mmol). The mixture was stirred at 78 ºC for 72 h, then the acid catalyst was removed by filtration and the filtrate was concentrated under vacuum. The product was crystallized from dichloromethane/methanol affording the compound 4b (172 mg, 78 %). 1 H NMR (400 MHz, CD3OD) Quinic acid 1,5-lactone (5) [8] . To a solution of quinic acid (192 mg, 1 mmol) in ethanol (4 mL) was added deloxan (13 mg, 0.01 mmol). The mixture was stirred at 78 ºC for 24h then the acid catalyst was removed by filtration, the filtrate was concentrated under vacuum and purified by column chromatography on silica gel (dicloromethane/MeOH 5S,7R,8S,9R)-7,8,9-trihydroxy-2,2-dimethyl-1,3-dioxaspiro [4.5] decan-4-one (7) . To a solution of quinic acid (192 mg, 1 mmol) in acetone (4 mL) was added deloxan (13 mg, 0.01 mmol) and 2,2-dimethoxypropane (364 mg, 430 L, 3.5 mmol). The mixture was stirred at 56 ºC for 4 h, then TBD-PS (33 mg, 0.1 mmol) and ethanol (4 mL) were added. The mixture was stirred at 0 ºC for 24 h, then the catalysts were removed by filtration, the filtrate was concentrated under vacuum and purified by column chromatography on silica gel (hexanes/EtOAc = 6:4, Rf 0.3), affording the 
